SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $107,920,350 |
| Positions | 8 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| KESTRA MED TECHNOLOGIES LTD | KMTS | SHS | $58,067,283 | 2,282,519 |
| WHITEHAWK THERAPEUTICS INC | WHWK | COM | $22,264,818 | 4,861,314 |
| ALUMIS INC | ALMS | COM | $7,110,190 | 252,672 |
| CERIBELL INC | CBLL | COM | $6,659,641 | 342,398 |
| INVENTIVA SA | IVA | ADS | $5,670,000 | 1,500,000 |
| PROMIS NEUROSCIENCES INC | PMN | COM SHS | $4,339,642 | 329,760 |
| PERSPECTIVE THERAPEUTICS INC | CATX | COM NEW | $3,598,945 | 1,055,409 |
| AMERICAN BITCOIN CORP. | ABTC | COM CL A | $209,831 | 308,076 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.